Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia V6T 1Z1, Canada.
Department of Neurology and Neurosurgery, McGill University, Montréal, Quebec H3A 2B4, Canada; Centre de Recherche du Centre Hospitalier de Université de Montréal, Montréal, Quebec H2X 0A9, Canada.
J Mol Biol. 2022 Aug 30;434(16):167697. doi: 10.1016/j.jmb.2022.167697. Epub 2022 Jun 23.
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease primarily impacting motor neurons. Mutations in superoxide dismutase 1 (SOD1) are the second most common cause of familial ALS. Several of these mutations lead to misfolding or toxic gain of function in the SOD1 protein. Recently, we reported that misfolded SOD1 interacts with TNF receptor-associated factor 6 (TRAF6) in the SOD1 rat model of ALS. Further, we showed in cultured cells that several mutant SOD1 proteins, but not wildtype SOD1 protein, interact with TRAF6 via the MATH domain. Here, we sought to uncover the structural details of this interaction through molecular dynamics (MD) simulations of a dimeric model system, coarse grained using the AWSEM force field. We used direct MD simulations to identify buried residues, and predict binding poses by clustering frames from the trajectories. Metadynamics simulations were also used to deduce preferred binding regions on the protein surfaces from the potential of the mean force in orientation space. Well-folded SOD1 was found to bind TRAF6 via co-option of its native homodimer interface. However, if loops IV and VII of SOD1 were disordered, as typically occurs in the absence of stabilizing Zn ion binding, these disordered loops now participated in novel interactions with TRAF6. On TRAF6, multiple interaction hot-spots were distributed around the equatorial region of the MATH domain beta barrel. Expression of TRAF6 variants with mutations in this region in cultured cells demonstrated that TRAF6 facilitates interaction with different SOD1 mutants. These findings contribute to our understanding of the disease mechanism and uncover potential targets for the development of therapeutics.
肌萎缩侧索硬化症(ALS)是一种主要影响运动神经元的致命神经退行性疾病。超氧化物歧化酶 1(SOD1)的突变是家族性 ALS 的第二大常见原因。这些突变中的一些导致 SOD1 蛋白的错误折叠或毒性获得功能。最近,我们报道了在 ALS 的 SOD1 大鼠模型中,错误折叠的 SOD1 与肿瘤坏死因子受体相关因子 6(TRAF6)相互作用。此外,我们在培养的细胞中表明,几种突变 SOD1 蛋白,但不是野生型 SOD1 蛋白,通过 MATH 结构域与 TRAF6 相互作用。在这里,我们通过使用 AWSEM 力场进行粗粒化的二聚体模型系统的分子动力学(MD)模拟,试图揭示这种相互作用的结构细节。我们使用直接 MD 模拟来识别埋藏残基,并通过轨迹的帧聚类来预测结合构象。元动力学模拟也用于从取向空间的平均势中推断蛋白质表面上的优先结合区域。发现结构良好的 SOD1 通过其天然同源二聚体界面的共选择与 TRAF6 结合。然而,如果 SOD1 的环 IV 和 VII 无序,如在缺乏稳定 Zn 离子结合时通常发生的那样,这些无序环现在与 TRAF6 参与新的相互作用。在 TRAF6 上,多个相互作用热点分布在 MATH 结构域β桶的赤道区域周围。在培养的细胞中表达该区域突变的 TRAF6 变体表明,TRAF6 促进与不同 SOD1 突变体的相互作用。这些发现有助于我们理解疾病机制,并揭示开发治疗药物的潜在目标。